Sign In
Buy RDY
$11.85
+0.0200 (+0.169%)
At Close: Jul 31, 2026
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
11:00am, Friday, 31'st Jul 2026
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi and Korsinsky PR Newswire NEW YORK, July 31, 2
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
10:07am, Friday, 31'st Jul 2026
Investigation focuses on RDY losses after Dr. Reddy's disclosed a ₹2.4 billion provision tied to out-of-spec semaglutide batches and shares fell approximately 9%. NEW YORK, July 31, 2026 /PRNewswire
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY)
10:07am, Wednesday, 29'th Jul 2026
RDY shares fell approximately 9% after Dr. Reddy's disclosed a ₹2.4 billion provision tied to out-of-spec semaglutide batches. The investigation focuses on the Company's regulatory statements about
RDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy's Laboratories (RDY)
10:07am, Tuesday, 28'th Jul 2026
NEW YORK--(BUSINESS WIRE)--RDY shareholders saw Dr. Reddy's Laboratories (NYSE: RDY) shares fall approximately 9% on July 22, 2026, after Q1 FY27 results included a ₹2.4 billion provision tied to ou
RDY shares fell approximately 9% after Q1 FY27 results showed a 5.66% year-over-year revenue decline and a 68.7% profit decline. The investigation focuses on investor losses tied to the market reactio
U.S. pharma tariffs 'can't be absorbed' and drug prices will increase, says Dr Reddy's CEO
02:31am, Friday, 24'th Jul 2026
In this CNBC exclusive, Dr. Reddy's Laboratories CEO Erez Israeli breaks down the company's recent Q1 earnings report. He addresses the temporary halt in Semaglutide production due to an impurity issu
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
10:24pm, Thursday, 23'rd Jul 2026
U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing
Dr Reddy's Laboratories Ltd (RDY) Shares Surge 3.7% -- What GF Score of 83 Tells Investors
06:47pm, Thursday, 23'rd Jul 2026
On July 23, 2026, Dr Reddy's Laboratories Ltd (RDY) shares rose 3.7%, bringing the current price to $11.80. The stock has experienced notable volatility, with a
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down
11:41am, Thursday, 23'rd Jul 2026
RDY's fiscal Q1 earnings and revenues miss estimates as weaker North America generics sales hurt results, sending shares down 9%.
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
05:10pm, Wednesday, 22'nd Jul 2026
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
Dr. Reddy's Laboratories Q1 Earnings Call Highlights
01:07pm, Wednesday, 22'nd Jul 2026
Dr. Reddy's Laboratories NYSE: RDY reported a year-over-year revenue decline and sharply lower profitability for the first quarter of fiscal 2027, as lower lenalidomide sales and semaglutide API-relat
Indian drugmaker Dr Reddy's posts quarterly profit slump
06:53am, Wednesday, 22'nd Jul 2026
Indian drugmaker Dr Reddy's reported a smaller-than-expected quarterly profit on Wednesday, as muted sales of a key generic oncology drug and pricing pressure weighed on the compe
Dr. Reddy’s Laboratories Ltd $RDY Holdings Lifted by Bessemer Group Inc.
04:03am, Sunday, 19'th Jul 2026
Bessemer Group Inc. boosted its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE: RDY) by 28.4% during the undefined quarter, according to its most recent disclosure with the Securities and Ex
Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk
05:02pm, Sunday, 12'th Jul 2026
Dr. Reddy's Laboratories NYSE: RDY said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide injection will temporarily delay commercial supplies, though management emphas
Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript
10:11am, Friday, 10'th Jul 2026
Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript
